Global variations in funding and use of hemodialysis accesses: an international report using the ISN Global Kidney Health Atlas
-
Published:2024-05-08
Issue:1
Volume:25
Page:
-
ISSN:1471-2369
-
Container-title:BMC Nephrology
-
language:en
-
Short-container-title:BMC Nephrol
Author:
Ghimire AnukulORCID, Shah Samveg, Chauhan Utkarsh, Ibrahim Kwaifa Salihu, Jindal Kailash, Kazancioglu Rumeyza, Luyckx Valerie A., MacRae Jennifer M., Olanrewaju Timothy O., Quinn Robert R., Ravani Pietro, Shah Nikhil, Thompson Stephanie, Tungsanga Somkanya, Vachharanjani Tushar, Arruebo Silvia, Caskey Fergus J., Damster Sandrine, Donner Jo-Ann, Jha Vivekanand, Levin Adeera, Malik Charu, Nangaku Masaomi, Saad Syed, Tonelli Marcello, Ye Feng, Okpechi Ikechi G., Bello Aminu K., Johnson David W.
Abstract
Abstract
Background
There is a lack of contemporary data describing global variations in vascular access for hemodialysis (HD). We used the third iteration of the International Society of Nephrology Global Kidney Health Atlas (ISN-GKHA) to highlight differences in funding and availability of hemodialysis accesses used for initiating HD across world regions.
Methods
Survey questions were directed at understanding the funding modules for obtaining vascular access and types of accesses used to initiate dialysis. An electronic survey was sent to national and regional key stakeholders affiliated with the ISN between June and September 2022. Countries that participated in the survey were categorized based on World Bank Income Classification (low-, lower-middle, upper-middle, and high-income) and by their regional affiliation with the ISN.
Results
Data on types of vascular access were available from 160 countries. Respondents from 35 countries (22% of surveyed countries) reported that > 50% of patients started HD with an arteriovenous fistula or graft (AVF or AVG). These rates were higher in Western Europe (n = 14; 64%), North & East Asia (n = 4; 67%), and among high-income countries (n = 24; 38%). The rates of > 50% of patients starting HD with a tunneled dialysis catheter were highest in North America & Caribbean region (n = 7; 58%) and lowest in South Asia and Newly Independent States and Russia (n = 0 in both regions). Respondents from 50% (n = 9) of low-income countries reported that > 75% of patients started HD using a temporary catheter, with the highest rates in Africa (n = 30; 75%) and Latin America (n = 14; 67%). Funding for the creation of vascular access was often through public funding and free at the point of delivery in high-income countries (n = 42; 67% for AVF/AVG, n = 44; 70% for central venous catheters). In low-income countries, private and out of pocket funding was reported as being more common (n = 8; 40% for AVF/AVG, n = 5; 25% for central venous catheters).
Conclusions
High income countries exhibit variation in the use of AVF/AVG and tunneled catheters. In low-income countries, there is a higher use of temporary dialysis catheters and private funding models for access creation.
Funder
International Society of Nephrology
Publisher
Springer Science and Business Media LLC
Reference48 articles.
1. Ravani P, Palmer SC, Oliver MJ, Quinn RR, MacRae JM, Tai DJ, et al. Associations between hemodialysis access type and clinical outcomes: a systematic review. J Am Soc Nephrol. 2013;24(3):465–73. 2. Ethier J, Mendelssohn DC, Elder SJ, Hasegawa T, Akizawa T, Akiba T, et al. Vascular access use and outcomes: an international perspective from the Dialysis outcomes and practice patterns study. Nephrol Dial Transpl. 2008;23(10):3219–26. 3. Lok CE, Huber TS, Lee T, Shenoy S, Yevzlin AS, Abreo K, et al. KDOQI Clinical Practice Guideline for Vascular Access: 2019 update. Am J Kidney Dis. 2020;75(4):S1–164. 4. Chan CT, Blankestijn PJ, Dember LM, Gallieni M, Harris DCH, Lok CE et al. Dialysis initiation, modality choice, access, and prescription: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2019;96(1):37–47. 5. Maguire IC, Browne LD, Dawood M, Leahy F, Ryan MC, White E, et al. Differential Impact of Central venous catheters versus Arteriovenous Fistulae on Quality of Life among Irish Haemodialysis patients. Kidney360. 2022;3(6):1065–72.
|
|